（文章来源：证券日报） 证券日报网2月10日讯，赛恩斯在接受调研者提问时表示，目前，公司铼资源综合回收技术在多宝山、 黑龙江紫金、吉林紫金、洛阳钼业成功实现了工业化应用，与吉林紫金、黑龙江紫金等企业合作的铼回 收项目已实现连续稳定生产。 ...

Core Viewpoint - China Railway announced that its new contract value for 2025 is projected to be 27,509 billion yuan, representing a year-on-year growth of 1.3% [1] Summary by Relevant Categories Company Performance - The new contract value for China Railway in 2025 is expected to reach 27,509 billion yuan [1] - This figure indicates a slight increase of 1.3% compared to the previous year [1]

Core Viewpoint - AVIC Xi'an Aircraft Industry Group announced that the second unlock condition of its first phase restricted stock incentive plan has been met, allowing 3,894,768 shares to be listed for trading on February 24, 2026, which represents 0.14% of the company's total share capital [2] Group 1 - The announcement was approved by the 17th meeting of the 9th Board of Directors held on February 3, 2026 [2] - The matter has also been authorized by the first extraordinary general meeting of shareholders in 2023 [2]

证券日报网讯 2月10日，艾德生物发布公告称，公司股东厦门科英投资合伙企业（有限合伙）于2026年 2月3日至2月9日通过集中竞价及大宗交易合计减持4775100股，占总股本1.22%，减持计划已完成，减 持后其持股比例由4.08%降至2.86%。 （文章来源：证券日报） ...

Core Viewpoint - The company is experiencing a scattered distribution of users in the high-end manufacturing sector, with its main calibration testing equipment primarily serving traditional fuel vehicle manufacturers [2] Group 1: Business Overview - The calibration testing equipment's demand in the new energy vehicle sector is currently limited, focusing mainly on temperature and humidity sensor calibration, thermal management system temperature control accuracy, pressure balance, and full temperature range performance testing [2] - The overall procurement volume for these calibration testing devices in the new energy vehicle segment is small, having a minimal impact on the company's revenue [2] Group 2: Future Outlook - The company is actively expanding its relevant scenarios and engaging with technical personnel to provide more suitable solutions, aiming for increased collaboration opportunities [2]

Group 1 - The company, Guyue Longshan, acknowledges the importance of normalizing and prolonging shareholder care activities, planning to incorporate such activities into a long-term shareholder service system [2] - The company intends to upgrade and optimize the format and content of these activities in conjunction with traditional Chinese festivals, aiming to offer more distinctive and shareholder-focused benefits related to Huangjiu [2] - The company is committed to continuously improving its shareholder return and care mechanisms, expressing a sincere approach to rewarding long-term investors who support the company [2]

（文章来源：证券日报） 证券日报网2月10日讯 ，赛恩斯在接受调研者提问时表示，在当前阶段，公司短期内将以战略资源储备 为主要方向，具体销售计划还需根据市场情况来确定。铼具有抗腐蚀、抗氧化、室温条件下稳定性好的 特性，金属铼在适当的条件下可长期保存。 ...

Group 1 - The core point of the article is the announcement by Leao Planning regarding a change in the company's continuous supervision representative due to work arrangement adjustments for Wang Yulu [2] - Guotou Securities has appointed Wang Jian to replace Wang Yulu as the company's continuous supervision sponsor representative, who will work alongside Liu Xi to fulfill supervisory responsibilities [2] - The supervisory period will continue until the regulatory obligations are fulfilled as per the requirements [2]

Core Viewpoint - The company focuses on rapidly developing treatment areas such as medical aesthetics, wound care, ophthalmology, orthopedics, and surgery, accelerating the transformation of innovative results [2] Group 1: Product Development - The company has received approvals for high-end hyaluronic acid products "Haimi" and "Haimi Moon White," as well as various mid-range and high-end artificial lenses and high-permeability corneal shaping lenses [2] - The company is expanding its product line in medical aesthetics and ophthalmology, with several key R&D projects underway, including painless cross-linked hyaluronic acid, medical cross-linked chitosan gel, enhanced water-light injection agents, and linear precision cross-linked water-light injection agents [2] Group 2: R&D Focus - Ongoing R&D projects include hydrophilic continuous vision artificial lenses, hydrophobic mold-injected extended depth of focus artificial lenses, intraocular filling biological gels, aqueous permeable PRL, high-permeability scleral lenses, and new high-permeability (DK180) corneal shaping lenses [2]

证券日报网讯 2月10日，通光线缆发布公告称，公司已完成注册资本的工商变更登记，注册资本由 45828.608万元整变更为46760.1335万元整，并取得南通市数据局换发的《营业执照》。 （文章来源：证券日报） ...